Personnel Management in Domestic and Foreign Regulatory Guidelines for the Manufacture of Sterile Pharmaceutical Products

被引：0
|
作者：
Wang, Sijin [1 ]
Wang, Ganggang [1 ]
Yu, Meng [1 ]
Ma, Shihong [1 ]
机构：
[1] NMPA Key Lab. for Quality Research and Evaluation of Chemical Drugs, National Institutes for Food and Drug Control, Beijing,100050, China
来源：
Chinese Journal of Pharmaceuticals | 2022年 / 53卷 / 08期
关键词：
D O I：
10.16522/j.cnki.cjph.2022.08.020
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1222 / 1226
相关论文
共 12 条
  • [1] THE MANUFACTURE AND CONTROL OF STERILE PHARMACEUTICAL PRODUCTS
    COULTHARD, CE
    CHEMISTRY & INDUSTRY, 1948, (15) : 234 - 234
  • [2] MICROBIOLOGICAL CONTROL IN MANUFACTURE OF STERILE PHARMACEUTICAL PRODUCTS
    BUHLMANN, X
    PHARMACEUTICA ACTA HELVETIAE, 1971, 46 (07): : 385 - +
  • [3] New Japanese Regulatory Frameworks for Post-Marketing Management of Pharmaceutical Products
    Kento Takamura
    Keisuke Tachibana
    Tetsuya Kusakabe
    Kiyohito Nakai
    Yasuo Tsutsumi
    Masuo Kondoh
    Pharmaceutical Research, 2020, 37
  • [4] New Japanese Regulatory Frameworks for Post-Marketing Management of Pharmaceutical Products
    Takamura, Kento
    Tachibana, Keisuke
    Kusakabe, Tetsuya
    Nakai, Kiyohito
    Tsutsumi, Yasuo
    Kondoh, Masuo
    PHARMACEUTICAL RESEARCH, 2020, 37 (07)
  • [5] IMPURITIES IN PHARMACEUTICAL PRODUCTS: AN OVERVIEW OF REGULATORY GUIDELINES, EMERGING DETECTION METHODS, RESIDUAL SOLVENTS AND GENOTOXIC ASPECTS
    Dragan, Andreea G.
    Cinteza, Otilia L.
    Weisssieker, Horst
    Schaff, Peter
    FRESENIUS ENVIRONMENTAL BULLETIN, 2009, 18 (01): : 3 - 11
  • [6] STRATEGIC BRAND MANAGEMENT IN DOMESTIC AND FOREIGN PRODUCTS OFFERED IN TURKISH MARKET AND COMPARISON OF BRAND EQUITY
    Savasci, Ipek
    MARKETING AND MANAGEMENT SCIENCES, 2008, : 96 - 100
  • [7] Use of "Big Data" to Evaluate Responses to Changes in Regulatory Guidelines: Trends in Genotoxicity Testing Packages for New Pharmaceutical Products
    Reeve, Lesley
    Baldrick, Paul
    Newell, Andrew
    Templeton, Scott
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2020, 54 (04) : 764 - 769
  • [8] Use of “Big Data” to Evaluate Responses to Changes in Regulatory Guidelines: Trends in Genotoxicity Testing Packages for New Pharmaceutical Products
    Lesley Reeve
    Paul Baldrick
    Andrew Newell
    Scott Templeton
    Therapeutic Innovation & Regulatory Science, 2020, 54 : 764 - 769
  • [9] Feasibility of wavelength dispersive X-ray fluorescence spectrometry for the determination of metal impurities in pharmaceutical products and dietary supplements in view of regulatory guidelines
    Figueiredo, Alexandra
    Fernandes, Tania
    Costa, Isabel Margarida
    Goncalves, Luisa
    Brito, Jose
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2016, 122 : 52 - 58
  • [10] Screening of pharmaceutical and personal care products (PPCPs) along wastewater treatment system equipped with root zone treatment: A potential model for domestic waste leachate management
    Kumar, Manish
    Silori, Rahul
    Mazumder, Payal
    Tauseef, Syed Mohammad
    JOURNAL OF ENVIRONMENTAL MANAGEMENT, 2023, 335
12